PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
16.80%
Gross profit growth above 1.5x STERV.HE's 4.73%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
19.63%
Positive EBIT growth while STERV.HE is negative. John Neff might see a substantial edge in operational management.
19.63%
Positive operating income growth while STERV.HE is negative. John Neff might view this as a competitive edge in operations.
18.73%
Positive net income growth while STERV.HE is negative. John Neff might see a big relative performance advantage.
21.43%
Positive EPS growth while STERV.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
21.43%
Positive diluted EPS growth while STERV.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-2.23%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.23%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
19.74%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
970.59%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-26.09%
Negative 10Y revenue/share CAGR while STERV.HE stands at 20.74%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.14%
5Y revenue/share CAGR under 50% of STERV.HE's 2.61%. Michael Burry would suspect a significant competitive gap or product weakness.
8.90%
3Y revenue/share CAGR 1.25-1.5x STERV.HE's 7.77%. Bruce Berkowitz might see better product or regional expansions than the competitor.
591.58%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
299.37%
5Y OCF/share CAGR above 1.5x STERV.HE's 85.07%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
258.96%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
148.99%
Below 50% of STERV.HE's 707.33%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
150.10%
5Y net income/share CAGR 1.25-1.5x STERV.HE's 134.34%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
142.86%
3Y net income/share CAGR 1.25-1.5x STERV.HE's 96.61%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
53.48%
5Y equity/share CAGR above 1.5x STERV.HE's 23.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
25.43%
3Y equity/share CAGR 1.25-1.5x STERV.HE's 18.58%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
AR growth well above STERV.HE's 3.68%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.73%
Inventory growth well above STERV.HE's 12.19%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.40%
Negative asset growth while STERV.HE invests at 5.91%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-11.02%
We’re deleveraging while STERV.HE stands at 33.10%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.